Determination of malondialdehyde in breath condensate

M. Lärstad, G. Ljungkvist, A. C. Olin, K. Torén (Göteborg, Sweden)

Source: Annual Congress 2001 - Asthma monitoring and therapy
Session: Asthma monitoring and therapy
Session type: Thematic Poster Session
Number: 1816
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Lärstad, G. Ljungkvist, A. C. Olin, K. Torén (Göteborg, Sweden). Determination of malondialdehyde in breath condensate. Eur Respir J 2001; 16: Suppl. 31, 1816

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Influence of sampling time on malondialdehyde levels and pH in exhaled breath condensate
Source: Eur Respir J 2003; 22: Suppl. 45, 38s
Year: 2003

Increased 8-isoprostane in the exhaled breath condensate of down patients
Source: Eur Respir J 2004; 24: Suppl. 48, 556s
Year: 2004

Mass-selective determination of free 3-nitrotyrosine in breath condensate
Source: Eur Respir J 2002; 20: Suppl. 38, 484s
Year: 2002

Determination of NO2-/NO3- level in exhaled breath condensate. Nitrate reduction with zinc
Source: Eur Respir J 2005; 26: Suppl. 49, 119s
Year: 2005

Malondialdehyde in exhaled breath condensate in different pulmonary diseases
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010

Parameters of oxidation in exhaled breath condensate
Source: Eur Respir J 2004; 24: Suppl. 48, 470s
Year: 2004

Rapid measurement of lactate in exhaled breath condensate
Source: Eur Respir J 2006; 28: Suppl. 50, 435s
Year: 2006

Measurement of surfactant phospholipids in exhaled breath condensate
Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement
Year: 2008

Validation of eicosanoid measurements in exhaled breath condensate
Source: Eur Respir J 2002; 20: Suppl. 38, 422s
Year: 2002

Correlation of LTB4 with α-amylase in exhaled breath condensate
Source: Eur Respir J 2005; 26: Suppl. 49, 372s
Year: 2005

N-acetylcysteine reduces 8-isoprostane levels in exhaled breath condensate and serum of COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 13s
Year: 2005

Dynamics of free radical indicators of exhaled breath condensate in smokers.
Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease
Year: 2019

Increase 8-Isoprostane in breath condensate in beta-thalassemia patients
Source: Eur Respir J 2004; 24: Suppl. 48, 679s
Year: 2004

Increased lactate concentrations in exhaled breath condensate (EBC) in COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 584s
Year: 2007

Exercise-induced changes in concentrations of cysteinyl-leukotrienes in exhaled breath condensate
Source: Eur Respir J 2004; 24: Suppl. 48, 680s
Year: 2004

Measurement of natrium chloride and adenosine concentration in exhaled breath condensate
Source: Eur Respir J 2002; 20: Suppl. 38, 281s
Year: 2002

Reproducibility of exhaled breath condensate markers
Source: Eur Respir J 2008; 32:
Year: 2008


The markers of free radical oxidation in exhaled breath condensate (EBC) during the long-term smoking
Source: Annual Congress 2009 - Tobacco smoke and inflammatory and immune effects
Year: 2009